Ratings
0
Nobody has rated this yet. Be the first!
Works
4
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study
Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
